Evaluation of the population safety of nonsteroidal anti-inflammatory drugs in the framework of the Pan-European SOS program: focus on aceclofenac

@article{Karateev2020EvaluationOT,
  title={Evaluation of the population safety of nonsteroidal anti-inflammatory drugs in the framework of the Pan-European SOS program: focus on aceclofenac},
  author={Andrei E. Karateev},
  journal={Neurology, neuropsychiatry, Psychosomatics},
  year={2020},
  volume={12},
  pages={109-113}
}
  • A. Karateev
  • Published 19 April 2020
  • Medicine
  • Neurology, neuropsychiatry, Psychosomatics
Since 2008, a group of international experts has been studying the population risk of serious complications of NSAIDs (the Safety Of nonSteroidal anti-inflammatory drugs (SOS) project) as part of the Seventh Framework Program of the European Union for Research and Technological Development (2007–2013). Four large-scale studies assessing the individual risk of gastrointestinal bleeding, heart failure (HF), ischemic stroke (IS), and myocardial infarction (MI) while taking various NSAIDs have been… 
1 Citations
Muscular factor in the development of musculoskeletal pain. Treatment options
TLDR
It is noted that a new form of tolperisone – Mydocalm®-Long 450 mg - can reduce the frequency of drug administration, provide a proven and predictable therapeutic effect, and increase treatment adherence.